Abstract:Objective To explore the clinical relationships of serum expressions of transforming growth factor (TGF-β1) and connective tissue growth factor (CTGF) with proliferative diabetic retinopathy (PDR). Methods A total of 230 patients with type 2 diabetes in our hospital from August 2013 to November 2015 were selected, and divided into the PDR group (120 cases) and the NPDR group (110 cases) according to whether they had retinopathy or not, then 110 healthy people were chosen as the control group. Serum TGF-β1 and CTGF and other clinical data of the three groups were collected, sorted and compared. Results Compared to the NPDR group and the control group, the serum level of low-density lipoprotein in the PDR group was significantly higher (P < 0.05).Compared to the NPDR group, the course of disease in the PDR group was significantly higher (P < 0.05). The serum levels of TGF-β1 and CTGF in the PDR group were significantly higher than those in the NPDR group and the control group (P < 0.05), but there were no significant differences between the NPDR group and the control group (P > 0.05). Conclusions Serum levels of TGF-β1 and CTGF are higher in the patients with PDR. And they have certain correlations with the onset and course of PDR.